Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

Naringin protects the nigrostriatal dopaminergic projection through induction of GDNF in a neurotoxin model of Parkinson's disease.

Leem E, Nam JH, Jeon MT, Shin WH, Won SY, Park SJ, Choi MS, Jin BK, Jung UJ, Kim SR.

J Nutr Biochem. 2014 Jul;25(7):801-6. doi: 10.1016/j.jnutbio.2014.03.006. Epub 2014 Apr 1.

PMID:
24797334
2.

Nobiletin protects dopaminergic neurons in the 1-methyl-4-phenylpyridinium-treated rat model of Parkinson's disease.

Jeong KH, Jeon MT, Kim HD, Jung UJ, Jang MC, Chu JW, Yang SJ, Choi IY, Choi MS, Kim SR.

J Med Food. 2015 Apr;18(4):409-14. doi: 10.1089/jmf.2014.3241. Epub 2014 Oct 17.

PMID:
25325362
3.

Naringin treatment induces neuroprotective effects in a mouse model of Parkinson's disease in vivo, but not enough to restore the lesioned dopaminergic system.

Kim HD, Jeong KH, Jung UJ, Kim SR.

J Nutr Biochem. 2016 Feb;28:140-6. doi: 10.1016/j.jnutbio.2015.10.013. Epub 2015 Nov 4.

PMID:
26878791
4.

Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.

Nam JH, Leem E, Jeon MT, Jeong KH, Park JW, Jung UJ, Kholodilov N, Burke RE, Jin BK, Kim SR.

Mol Neurobiol. 2015 Apr;51(2):487-99. doi: 10.1007/s12035-014-8729-2. Epub 2014 May 25.

PMID:
24859383
5.

Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.

Jung UJ, Jeon MT, Choi MS, Kim SR.

J Med Food. 2014 May;17(5):599-605. doi: 10.1089/jmf.2013.2926. Epub 2014 Mar 24.

PMID:
24660866
6.

Naringin: a protector of the nigrostriatal dopaminergic projection.

Jung UJ, Leem E, Kim SR.

Exp Neurobiol. 2014 Jun;23(2):124-9. doi: 10.5607/en.2014.23.2.124. Epub 2014 Jun 13. Review.

8.

GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.

Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A.

Brain. 2011 Aug;134(Pt 8):2302-11. doi: 10.1093/brain/awr149. Epub 2011 Jun 28.

PMID:
21712347
9.

Intracerebral administration of ultrasound-induced dissolution of lipid-coated GDNF microbubbles provides neuroprotection in a rat model of Parkinson's disease.

Wang X, Cui G, Yang X, Zhang Z, Shi H, Zu J, Hua F, Shen X.

Brain Res Bull. 2014 Apr;103:60-5. doi: 10.1016/j.brainresbull.2014.02.006. Epub 2014 Feb 26.

PMID:
24583079
10.

Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor.

Choi-Lundberg DL, Lin Q, Schallert T, Crippens D, Davidson BL, Chang YN, Chiang YL, Qian J, Bardwaj L, Bohn MC.

Exp Neurol. 1998 Dec;154(2):261-75.

PMID:
9878166
11.

Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.

Du Y, Li X, Yang D, Zhang X, Chen S, Huang K, Le W.

Exp Biol Med (Maywood). 2008 Jul;233(7):881-90. doi: 10.3181/0712-RM-329. Epub 2008 Apr 29.

PMID:
18445767
14.

Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo.

Hung KC, Huang HJ, Wang YT, Lin AM.

J Ethnopharmacol. 2016 Dec 24;194:522-529. doi: 10.1016/j.jep.2016.10.040. Epub 2016 Oct 11.

PMID:
27742410
15.
16.
17.
18.

Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.

Jakobsen B, Gramsbergen JB, Møller Dall A, Rosenblad C, Zimmer J.

Eur J Neurosci. 2005 Jun;21(11):2939-48.

PMID:
15978005
20.

Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.

Connor B, Kozlowski DA, Schallert T, Tillerson JL, Davidson BL, Bohn MC.

Gene Ther. 1999 Dec;6(12):1936-51.

Supplemental Content

Support Center